| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.125 |
0.063 － 0.125 |
Biapenem |
952 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.125 |
0.063 － 0.125 |
Meropenem (Merrem) |
952 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.125 |
0.063 － 2 |
Moxifloxacin (BAY 12-8039, Avelox) |
19 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.25 |
0.032 － 8 |
R-95867 |
600 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.25 |
≥0.063 － 0.25 |
Faropenem |
56 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.25 |
0.063 － 4 |
Gatifloxacin (Tequin) |
109 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
1 |
0.06 － 2 |
Levofloxacin (Levaquin, Quixin) |
1601 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
1 |
0.125 － 32 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1464 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
8 |
≤0.06 － >16 |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
8 |
0.125 － 64 |
Levofloxacin (Levaquin, Quixin) |
1464 |
| Staphylococcus aureus (methicillin-susceptible) |
0.13 |
0.13 |
0.06 － 0.5 |
Daptomycin (Cubicin) |
7 |
| Staphylococcus aureus (methicillin-susceptible) |
0.2 |
0.2 |
0.1 － 0.39 |
Faropenem |
40 |
| Staphylococcus aureus (methicillin-susceptible) |
0.2 |
0.2 |
0.1 － 0.39 |
Levofloxacin (Levaquin, Quixin) |
17 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.03 － 0.5 |
TAK-599 |
162 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.06 － 0.25 |
Sparfloxacin (AT-4140, Zagam) |
374 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.06 － 0.5 |
Chloroeremomycin (LY264826, A-82846B) |
51 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.06 － 0.5 |
LY 191145 |
51 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.06 － 0.5 |
Telavancin (TD-6424, Vibativ) |
73 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 0.25 |
Levofloxacin (Levaquin, Quixin) |
175 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
186 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
73 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 1 |
Tigecycline (GAR-936, Tigacyl) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 － 2 |
Imipenem |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － >16 |
Ertapenem (Invanz) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 16 |
Fusidic acid (Fucidin) |
604 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － >32 |
Quinupristin/Dalfopristin (Synercid) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.125 － 0.5 |
Cefdinir (Omnicef, Cefdiel) |
317 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.125 － 0.5 |
Levofloxacin (Levaquin, Quixin) |
317 |